Log In
BCIQ
Print this Print this
 

fenretinide (RT-101)

Also known as: formerly ST-602

  Manage Alerts
Collapse Summary General Information
Company ReVision Therapeutics Inc.
DescriptionOral synthetic retinoid
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat geographic atrophy (GA) in patients with age-related macular degeneration (AMD)
Regulatory Designation U.S. - Fast Track (Treat geographic atrophy (GA) in patients with age-related macular degeneration (AMD))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today